By Atman Rathod, Executive Director, CMARIX
LinkedIn: Atman Rathod
LinkedIn: CMARIX
Clinical AI is becoming part of how healthcare organizations analyze data, support clinicians, monitor patients, and improve care delivery. At the same time, these applications are handling some of the most sensitive information available: patient records, medical images, laboratory results, treatment histories, and genetic data.
This creates a tension between compliance and innovation. Healthcare providers want the benefits of AI without creating new privacy, security, or regulatory risks. The technology is also expanding at an annual rate of 37%, making responsible technology adoption even more important.
Developers and healthcare organizations must embed compliance directly into an application’s foundation from day one, rather than treating it as a final pre-launch checklist.
Understanding the FDA Framework
The FDA’s role depends on what a clinical AI application does and how it is used. Not every healthcare software product is regulated as a medical device, but software that performs certain medical functions may fall under FDA oversight.
AI application that organizes information differs greatly from one that analyzes patient data and supports diagnosis or treatment decisions.
Organizations developing clinical AI need to first understand the intended use of the application. They then need to determine whether the software falls within an applicable FDA framework and what regulatory requirements may apply.
AI also creates an additional challenge because the system may change or improve over time. A conventional software application usually follows a defined development cycle. An AI system can involve changing models, new training data, and updated performance.
That’s why organizations need clear processes for validating changes and monitoring performance after deployment.
Patient Data Security Starts With the Architecture
Clinical AI applications often connect to multiple healthcare systems. They may access EHRs, laboratory systems, imaging platforms, health information exchanges, or other clinical databases.
Each connection creates another point that needs protection.
Security therefore starts with the architecture rather than with a final security test. Organizations need to control how data enters the system, where it is stored, who can access it, and how it moves between systems.
Encryption is a good way to protect sensitive information during transmission as well as when it’s stored. Access controls must enforce the principle of least privilege, granting users and systems only the minimum permissions required to perform their tasks.
An AI model can not become secure on its own because the underlying healthcare system is secure. We need to manage all the aspects: the model, APIs, databases, integrations, and supporting infrastructure.
Protecting Data Used to Train AI
Training data creates another important concern.
Clinical AI systems sometimes require large datasets to identify patterns and improve performance. However, using patient information for training requires careful consideration of privacy, authorization, data minimization, and applicable regulations.
Organizations should know exactly what information they are using and why they need it. When possible, they can reduce exposure by removing direct identifiers or using appropriately de-identified datasets.
Data governance shouldn’t stop after you train the AI model. Your team needs a clear plan for where the data comes from, who gets to see it, where it lives, and exactly when to delete it.
Otherwise, an organization will face a large collection of sensitive information without having controls around it.
Interoperability Creates More Security Challenges
Clinical AI rarely works in isolation. It needs access to existing healthcare information to provide useful results.
That makes interoperability important, but it also creates additional security considerations.
Applications commonly interact with systems through APIs and healthcare data standards. Every connection needs authentication, authorization, monitoring, and appropriate data handling.
A poorly secured integration can expose more information than the AI application itself.
Before launch, teams need to map out exactly how data moves. You have to know what information travels between systems, who owns it, who has access, and what the backup plan is if a connection breaks.
This helps teams to identify unnecessary data transfers and reduce the amount of sensitive information moving through the environment.
AI Needs Ongoing Monitoring
A clinical AI application should not be treated as finished when it goes live.
Performance can change as patient populations, clinical practices, data sources, or operating conditions change. A model that performs well during testing may behave differently when it encounters real-world data.
Organizations need to monitor performance and investigate unexpected results. They should also maintain records of model versions, training data, testing results, updates, and important system changes.
This is particularly important when an AI system supports clinical decisions. Healthcare professionals need to understand the system’s role and know when they should question or override its output.
Human oversight remains important, especially when an AI recommendation can affect patient care.
Conclusion
As clinical AI evolves, healthcare organizations need continuous, team-wide compliance instead of one-time reviews. Before launching, teams must define the tool’s use, secure data flows, and plan for long-term monitoring. True success means building transparent, safe AI that protects patients and works reliably within real-world regulations.